Prospective observational study to evaluate Lemborexant Utility in iNsomniA women with bReast cancer(WJOG14921B)
Latest Information Update: 04 Jul 2023
At a glance
- Drugs Lemborexant (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- Acronyms LUNAR
- 06 Jun 2023 Trial design presented at the 59th Annual Meeting of the American Society of Clinical Oncology
- 02 Sep 2022 Planned End Date changed from 28 Sep 2024 to 1 Dec 2024.
- 02 Sep 2022 Status changed from not yet recruiting to recruiting.